Login
Home / AMFPF : OTC
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis News Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Amplifon S.p.A.

$11.21 -$5.28 (-32.02%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$11.21
Day Range
$11.21$12.02
Year Range
$9.46$18.33
Market Cap
2.97B
AVG Volume
16
Trailing/Forward PE
39.54/12.63
PEG ratio
1.63
Dividend Yield
2.52%
Next Earnings Date
2026-10-29
Primary Exchange
Other OTCUS
Revenue (EUR)
0200M400M600M800M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Net Income (EUR)
020M40M60M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Operating Income (EUR)
025M50M75M100M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EBITDA (EUR)
050M100M150M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash Flows (EUR)
050M100M150M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPS (EUR)
00.10.20.324 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Expenses (EUR)
020M40M60M80MSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash & Debt (EUR)
0500M1B1.5B2BCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Debt ratios
0123424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Margins
0%50%100%150%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Return on Capital
0%2%4%6%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Shares Outstanding
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Dividends (EUR)
00.10.20.30.4May 16May 17May 18May 19May 21May 22May 23May 24May 25May 26
Book Value Per Share (EUR)
024624 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Total Assets (EUR)
01B2B3B4B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PE Ratio
10203040med 27.86Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Free Cash Flow Yield
0%5%10%15%20%med 8.61%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Sales
0.511.522.53med 1.39Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EV/EBITDA
68101214med 8.88Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price/Operating Cashflow
05101520med 8.31Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Book
123456med 3.15Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Amplifon S.p.A.
AMFPF
Stockpicker

Video analysis: AMFPF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: AMFPF

Reviewing Amplifon (OTCMKTS:AMFPF) & Exagen (NASDAQ:XGN)

defenseworld.net · 24 Aug 2026

Reviewing Amplifon (OTCMKTS:AMFPF) & Exagen (NASDAQ:XGN)

Amplifon (OTCMKTS:AMFPF - Get Free Report) and Exagen (NASDAQ: XGN - Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, analyst recommendations, risk, profitability and valuation. Analyst Ratings This is a breakdown of current ratings and

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.